Differential capacity of the parthenogenetic embryonic stem cells (PESCs) is still under controversy and the mechanisms of its neural induction are yet poorly understood. Here we demonstrated neural lineage induction of PESCs by addition of insulin-like growth factor-2 (Igf2), which is an important factor for embryo organ development and a paternally expressed imprinting gene. Murine PESCs were aggregated to embryoid bodies (EBs) by suspension culture under the leukemia inhibitory factor-free condition for 4 days. To test the effect of exogenous Igf2, 30 ng/ml of Igf2 was supplemented to EBs induction medium. Then neural induction was carried out with serum-free medium containing insulin, transferrin, selenium, and fibronectin complex (ITSFn) for 12 days. Normal murine embryonic stem cells derived from fertilized embryos (ESCs) were used as the control group. Neural potential of differentiated PESCs and ESCs were analyzed by immunofluorescent labeling and real-time PCR assay (Nestin, neural progenitor marker; Tuj1, neuronal cell marker; GFAP, glial cell marker). The differentiated cells from both ESC and PESC showed heterogeneous population of Nestin, Tuj1, and GFAP positive cells. In terms of the level of gene expression, PESC showed 4 times higher level of GFAP expression than ESCs. After exposure to Igf2, the expression level of GFAP decreased both in derivatives of PESCs and ESCs. Interestingly, the expression level of Tuj1 increased only in ESCs, not in PESCs. The results show that IGF2 is a positive effector for suppressing over-expressed glial differentiation during neural induction of PESCs and for promoting neuronal differentiation of ESCs, while exogenous Igf2 could not accelerate the neuronal differentiation of PESCs. Although exogenous Igf2 promotes neuronal differentiation of normal ESCs, expression of endogenous Igf2 may be critical for initiating neuronal differentiation of pluripotent stem cells. The findings may contribute to understanding of the relationship between imprinting mechanism and neural differentiation and its application to neural tissue repair in the future.

Previously we have succeeded to isolate stem cells (HEAC) from human eyelid adipose tissue, and functionally differentiate them into insulin-secreting cells. In the present study, we examined whether insulin family members might affect the insulinogenic differentiation of HEAC. Insulin treatment during culture affected little on the insulin and c-peptide secretions from HEAC after culture. However, insulin-like growth factor (IGF) 1 treatment decreased both secretions, whereas IGF2 greatly increased the secretions in a glucose-dependent manner. HEAC treated with IGF2 showed stronger expression of Pdx1, Isl1, Pax6 and PC1/3 genes compared to the control. They also showed distinct staining with insulin and c-peptide antibodies, and dithizone. While insulin or IGF2 treatment increased total cell number by 1.3- or 1.5-fold, respectively, each treatment increased the amount of insulin secretion by 27.1- or 78.1-fold, respectively. IGF2-enhanced insulinogenic differentiation was completely blocked by an antibody against insulin receptor (IR), but not by an antibody against IGF1 receptor (IGF1R). Differentiated HEAC showed expression of both IR and IGF1R genes while they expressed neither IGF2 nor IGF2R genes. Based upon these results, it is suggested that whereas IGF1 might inhibit the insulinogenic differentiation of HEAC, insulin and IGF2 could enhance the differentiation, and that the enhancing effect could be mediated via IR.